{"slideshow_credits": null, "snippet": "The new commissioner, who has long-standing ties to the drug industry, must keep the agency from succumbing to industry demands.", "abstract": "Editorial calls on Senate to scrutinize Dr Robert Califf\u2019s ties to pharmaceutical industry for conflicts of interest before confirming him as head of Food and Drug Administration; cites respected cardiologist and researcher's history of payments as consultant to industry and his remarks in speech that regulations were 'barrier' to innovation. ", "section_name": "Opinion", "print_page": "22", "document_type": "article", "byline": {"person": [], "original": "By THE EDITORIAL BOARD", "organization": "THE EDITORIAL BOARD"}, "web_url": "http://www.nytimes.com/2015/11/16/opinion/questions-for-president-obamas-nominee-to-lead-the-fda.html", "lead_paragraph": "The new commissioner, who has long-standing ties to the drug industry, must keep the agency from succumbing to industry demands.", "headline": {"print_headline": "Questions for the F.D.A. Nominee", "main": "Questions for President Obama\u2019s Nominee to lead the F.D.A.", "content_kicker": "Editorial", "kicker": "Editorial"}, "_id": "564991c638f0d81963b74634", "word_count": "408", "multimedia": [{"height": 126, "url": "images/2015/11/14/opinion/16mon3web/16mon3web-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/14/opinion/16mon3web/16mon3web-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/11/14/opinion/16mon3web/16mon3web-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/14/opinion/16mon3web/16mon3web-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/14/opinion/16mon3web/16mon3web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/14/opinion/16mon3web/16mon3web-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-16T00:00:00Z", "source": "The New York Times", "news_desk": "Editorial", "keywords": [{"name": "subject", "value": "Editorials", "is_major": "Y", "rank": "1"}, {"name": "persons", "value": "Califf, Robert M", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Project on Government Oversight", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Duke University Medical Center", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "Editorial"}